MedTrace Logo

Evaluation of Therapeutic Response in Spinal Muscular Atrophy Using Multispectral Optoacoustic Tomography (MSOT) and Magnetic Resonance Imaging (MRI)

NCT04262570 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-02-28

No results posted yet for this study

Summary

This study aims to refine the capability of Multispectral Optoacoustic Tomography (MSOT) and Magnet Resonance Imaging (MRI) to characterise the molecular composition of muscle tissue non-invasively and to evaluate the therapeutic response in patients with spinal muscular atrophy (SMA) over time.

Conditions

Interventions

DEVICE

Multispectral Optoacoustic Tomography (MSOT) and Magnetic Resonance Imaging (MRI)

Non-invasive transcutaneous imaging of molecular muscle components

Sponsors & Collaborators

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Ferdinand Knieling, MD · University Hospital Erlangen, Department of Pediatric and Adolescent Medicine

  • Matthias Türk, MD · University Hospital Erlangen, Department of Neurology

  • Armin Nagel, MD · University Hospital Erlangen, Department of Radiology

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-25
Primary Completion
2021-12-31
Completion
2022-02-28

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04262570 on ClinicalTrials.gov